Relating to the establishment of the sickle cell disease registry.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.
Relating to the Rita Littlefield Chronic Kidney Disease Centralized Resource Center established within the Health and Human Services Commission.
Relating to the Rita Littlefield Chronic Kidney Disease Centralized Resource Center established within the Health and Human Services Commission.
Relating to the registration of and certain other requirements relating to data brokers; providing a civil penalty and authorizing a fee.
Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by qualifying patients with certain debilitating medical conditions and the licensing of dispensing organizations and cannabis testing facilities; authorizing fees.
Relating to sickle cell disease health care improvement and the sickle cell task force.
Relating to the establishment by certain counties and hospital districts of disease control pilot programs to reduce the risk of certain infectious and communicable diseases; authorizing fees.